In the current study, we further document that BRD5529 can significantly reduce lung inflammation in a mouse model of active PCP, providing further support that targeting CARD9 may represent an additional therapeutic approach to blunt exuberant and deleterious lung inflammation during severe Pneumocystis pneumonia (48). This evidence concerns the gene CARD9 and pneumocystosis.